Phase I studies in patients with liver cirrhosis.
Wensing
G
G
Institut für Klinische Pharmakologie, Bayer AG, Wuppertal, Germany.
D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000378:metabolism*; D018579:Patient Selection; D010599:Pharmacokinetics; D010600:Pharmacology